News
Key Details and Listing Information<br />The bidding for the Anthem Biosciences Initial Public Offering (IPO) took place from ...
The benchmark indices, Sensex and Nifty, are likely to see movement today, driven by multiple factors, including the release ...
Dr Reddys Laboratories announced that United States Food & Drug Administration (USFDA) completed a GMP and a Pre-Approval Inspection (PAI) at its formulations manufacturing facility FTO 11 in ...
The Indian stock market corrected in July, with the Nifty down 2.15%. Jigar Patel recommends short-term buys, including Varun ...
Hong Kong’s Hang Seng surged over 0.5%, China’s Shanghai Composite added 0.45%, while Singapore’s Straits Times rose up to ...
IDFC First Bank : Warburg Pincus, through its investment arm Currant Sea Investments B.V., has received regulatory approval ...
The IPO opened for subscription between July 14 and July 16, and was subscribed 67.42 times in total. Highest demand came ...
Nifty futures on the NSE International Exchange traded 38.80 points, or 0.16 per cent, down at 24,993.50, hinting at a ...
SEBI lifts trading ban on Wall Street HFT firm; index options giant to face tighter surveillance as probe continues.
Shares of firms like UltraTech, Eternal, RIL, ICICI Bank, HDFC Bank, Jio Financials, and others will be in focus on ...
Looking for stocks to buy today? Market experts Raja Venkatraman, Ankush Bajaj, Trade Brains Portal, and MarketSmith India ...
Bengaluru-based Anthem Biosciences sold its shares in the price band of Rs 540-570 apiece, which could be applied for a minimum of 26 shares and its multiples to raise Rs 3,395 crore.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results